ORCID as entered in ROS
https://orcid.org/0000-0002-2277-8337
Select Publications
Conference Papers
, 2023, 'REAL-WORLD UTILISATION AND SWITCHING BETWEEN JANUS KINASE INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN THE AUSTRALIAN OPAL DATASET', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 36 - 36
, 2023, 'RECAPTURE RATES WITH IXEKIZUMAB AFTER WITHDRAWAL OF THERAPY IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: RESULTS AT WEEK 104 FROM A RANDOMIZED PLACEBO-CONTROLLED WITHDRAWAL STUDY', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 37 - 38
, 2023, 'SAFETY AND EFFICACY OF IXEKIZUMAB TREATMENT IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: 3-YEAR RESULTS FROM THE COAST PROGRAMME', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 37 - 37
, 2022, 'A Double-Blind, Placebo-Controlled, Ascending Dose Phase 2a Study of ABP-671, a Novel, Potent and Selective URAT1 Inhibitor, in Patients with Gout or Hyperuricemia', in ARTHRITIS & RHEUMATOLOGY, WILEY, PA, Philadelphia, pp. 3601 - 3603, presented at
, 2022, 'Consistent Long-Term Guselkumab Efficacy Across Psoriatic Arthritis Domains Irrespective of Baseline Patient Characteristics', in ARTHRITIS & RHEUMATOLOGY, WILEY, PA, Philadelphia, pp. 4216 - 4218, presented at
, 2022, 'Efficacy of Guselkumab in Three Cohorts of Biologic-Naive PsA Patients with Axial Involvement Defined Based on Imaging and Machine-Learning Criteria: Pooled Analysis of Two Phase 3 Studies', in ARTHRITIS & RHEUMATOLOGY, WILEY, PA, Philadelphia, pp. 2053 - 2056, presented at
, 2022, 'A PHASE 4, LONGITUDINAL, SINGLE-ARM, OPEN-LABEL TREATMENT STUDY OF SUBCUTANEOUS GOLIMUMAB EFFECTIVENESS ASSESSED BY BOTH SPEED OF MAGNETIC RESONANCE IMAGING (MRI) CHANGES IN THE HAND/WRIST AND CLINICAL RESPONSE OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 22 - 22
, 2022, 'IXEKIZUMAB SHOWS A PATTERN OF PAIN IMPROVEMENT IN PATIENTS WITH AND WITHOUT MEASURABLE INFLAMMATION IN PSORIATIC ARTHRITIS', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 32 - 32
, 2022, 'USABILITY AND ACCEPTABILITY OF A NEW AUTOINJECTOR DEVICE AND ITS ASSOCIATED APP IN AUSTRALIAN RHEUMATOLOGY PATIENTS', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 24 - 25
, 2021, 'The OMERACT Knee Inflammation MRI Scoring System: Validation of Quantitative Methodologies and Tri-compartmental Overlays by Comparison with the MRI Osteoarthritis Knee Score', in ARTHRITIS & RHEUMATOLOGY, WILEY, ELECTR NETWORK, pp. 432 - 434, presented at
, 2021, 'THE IMPACT OF PERIPHERAL ARTICULAR MANIFESTATIONS ON THE EFFICACY OF IXEKIZUMAB IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS', in RHEUMATOLOGY, OXFORD UNIV PRESS, pp. 95 - +, http://dx.doi.org/10.1093/rheumatology/keab247.173
, 2021, 'EFFICACY OF BARICITINIB IN PATIENTS WITH MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS WITH 3 YEARS OF TREATMENT: RESULTS FROM A LONG-TERM STUDY', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 23 - 23
, 2021, 'RENAL FUNCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING BIOLOGIC OR TARGETED SYNTHETIC DISEASE MODIFYING ANTIRHEUMATIC DRUGS WITHIN THE AUSTRALIAN OPAL DATASET', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 27 - 27
, 2021, 'SAFETY PROFILE OF BARICITINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS UP TO 8.4 YEARS: AN UPDATED INTEGRATED SAFETY ANALYSIS', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 24 - 24
, 2020, 'Efficacy of Filgotinib in Patients with Rheumatoid Arthritis with Poor Prognostic Factors: Post Hoc Analysis', in ARTHRITIS & RHEUMATOLOGY, WILEY, ELECTR NETWORK, presented at
, 2020, 'Role of Artificial Intelligence in Assessment of Peripheral Joint MRI in Inflammatory Arthritis: A Systematic Review and Meta-analysis', in ARTHRITIS & RHEUMATOLOGY, WILEY, ELECTR NETWORK, presented at
, 2020, 'Efficacy of Filgotinib in Patients with Rheumatoid Arthritis with Poor Prognostic Factors: Post Hoc Analysis of FINCH 3', in SWISS MEDICAL WEEKLY, E M H SWISS MEDICAL PUBLISHERS LTD, pp. 9S - 10S
, 2020, 'EFFICACY OF FILGOTINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH POOR PROGNOSTIC FACTORS: POST HOC ANALYSIS OF FINCH 3', in ANNALS OF THE RHEUMATIC DISEASES, BMJ PUBLISHING GROUP, ELECTR NETWORK, pp. 308 - 309, presented at
, 2020, 'IXEKIZUMAB SIGNIFICANTLY IMPROVES SIGNS, SYMPTOMS AND SPINAL INFLAMMATION OF ACTIVE ANKYLOSING SPONDYLITIS/RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 16-WEEK RESULTS OF A PHASE 3 RANDOMIZED, ACTIVE AND PLACEBO-CONTROLLED TRIAL', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 12 - 13
, 2019, 'Novel Computer Assisted Methodology for Quantitative Assessment of MRI Treatment Responses to Apremilast in Patients with Psoriatic Arthritis', in ARTHRITIS & RHEUMATOLOGY, WILEY, GA, Atlanta, presented at
, 2019, 'Evaluation of Effectiveness and Usage Patterns of Tofacitinib in Treatment of Rheumatoid Arthritis in Australia: An Analysis from the OPAL-QUMI Real World Dataset', in ARTHRITIS & RHEUMATOLOGY, WILEY, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000507466902257&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'Ixekizumab significantly improves signs, symptoms and spinal inflammation of active ankylosing spondylitis/radiographic axial spondyloarthritis: 16-week results of a phase 3 randomised, active and placebo-controlled trial', in SWISS MEDICAL WEEKLY, E M H SWISS MEDICAL PUBLISHERS LTD, pp. 16S - 17S
, 2019, 'EVALUATION OF EFFECTIVENESS AND USAGE PATTERNS OF TOFACITINIB IN TREATMENT OF RHEUMATOID ARTHRITIS IN AUSTRALIA: AN ANALYSIS FROM THE OPAL-QUMI REAL WORLD DATASET', in ANNALS OF THE RHEUMATIC DISEASES, BMJ PUBLISHING GROUP, SPAIN, Madrid, pp. 740 - 741, presented at
, 2019, 'Tofacitinib 5 mg Twice Daily in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs: A Comprehensive Review of Phase 3 Efficacy and Safety', in Journal of Clinical Rheumatology, pp. 115 - 126, http://dx.doi.org/10.1097/RHU.0000000000000786
, 2018, 'Development and Preliminary Validation of an Omeract Magnetic Resonance Imaging (MRI) Scoring System for Ankle Enthesitis in Spondyloarthritis', in ARTHRITIS & RHEUMATOLOGY, WILEY, IL, Chicago, presented at
, 2018, 'Validity and Responsiveness of Inflammation and Joint Damage Scores Based on the Omeract Rheumatoid Arthritis MRI Scoring System', in ARTHRITIS & RHEUMATOLOGY, WILEY, IL, Chicago, presented at
, 2018, 'DEVELOPMENT AND PRELIMINARY VALIDATION OF AN OMERACT MRI ENTHESITIS SCORING SYSTEM FOR THE ANKLE IN SPONDYLOARTHRITIS', in ANNALS OF THE RHEUMATIC DISEASES, BMJ PUBLISHING GROUP, NETHERLANDS, Amsterdam, pp. 1690 - 1690, presented at
, 2018, 'INITIAL DEVELOPMENT OF A WHOLE-BODY MAGNETIC RESONANCE IMAGING INFLAMMATION INDEX FOR ACTIVE DISEASE OF PERIPHERAL JOINTS AND ENTHESES IN PATIENTS WITH INFLAMMATORY ARTHRITIS', in ANNALS OF THE RHEUMATIC DISEASES, BMJ PUBLISHING GROUP, NETHERLANDS, Amsterdam, pp. 1183 - 1184, presented at
, 2018, 'LONG-TERM (5-YEAR) EFFICACY AND SAFETY OF APREMILAST MONOTHERAPY IN DMARD-NAIVE SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS', in ANNALS OF THE RHEUMATIC DISEASES, BMJ PUBLISHING GROUP, NETHERLANDS, Amsterdam, pp. 1576 - 1577, presented at
, 2018, 'REASONS FOR BDMARD CESSATION AND SUBSEQUENT PERSISTENCE OF SECOND LINE TREATMENT IN A LARGE REAL WORLD RHEUMATOID ARTHRITIS REGISTRY', in ANNALS OF THE RHEUMATIC DISEASES, BMJ PUBLISHING GROUP, NETHERLANDS, Amsterdam, pp. 943 - 943, presented at
, 2018, 'VALIDATION OF WEB-BASED CALIBRATION MODULES FOR IMAGING SCORING SYSTEMS BASED ON PRINCIPLES OF ARTIFICIAL INTELLIGENCE: THE SPARCC MRI SACROILIAC JOINT INFLAMMATION SCORE', in ANNALS OF THE RHEUMATIC DISEASES, BMJ PUBLISHING GROUP, NETHERLANDS, Amsterdam, pp. 822 - 822, presented at
, 2018, 'SUMMARY OF BARICITINIB EFFECT ON PATIENT-REPORTED OUTCOMES (PROS) IN METHOTREXATE-INADEQUATE RESPONDER PATIENT POPULATION', in RHEUMATOLOGY, OXFORD UNIV PRESS, ENGLAND, Liverpool, presented at
, 2018, 'REASONS FOR BDMARD CESSATION AND SUBSEQUENT PERSISTENCE OF SECOND LINE TREATMENT IN A LARGE REAL WORLD RHEUMATOID ARTHRITIS (RA) REGISTRY', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 20 - 20
, 2018, 'SUMMARY OF BARICITINIB EFFECT ON PATIENT-REPORTED OUTCOMES (PROS) IN METHOTREXATE-INADEQUATE RESPONDER PATIENT POPULATION', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 42 - 43
, 2018, 'Summary of baricitinib effect on patient-reported outcomes in a methotrexate-inadequate responder patient population', in SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, TAYLOR & FRANCIS LTD, pp. 30 - 31
, 2017, 'Fatigue, Poor Health and Mood Disturbance Persist in Rheumatoid Arthritis and Psoriatic Arthritis Patients Despite Disease Remission: The OPAL Deeper Study', in ARTHRITIS & RHEUMATOLOGY, WILEY, CA, San Diego, presented at
, 2017, 'Long-Term (4-Year) Efficacy and Safety of Apremilast Monotherapy in DMARD-Naive Subjects with Active Psoriatic Arthritis', in ARTHRITIS & RHEUMATOLOGY, WILEY, CA, San Diego, presented at
, 2017, 'QUANTITATIVE 3D IMAGING OF TENOSYNOVITIS AND BONE MARROW EDEMA BY DCE-MRI IS A SENSITIVE MEASURE OF RESPONSE TO THERAPY IN RHEUMATOID ARTHRITIS', in ANNALS OF THE RHEUMATIC DISEASES, BMJ PUBLISHING GROUP, SPAIN, Madrid, pp. 1010 - 1010, presented at
, 2017, 'MAGNETIC RESONANCE IMAGING (MRI) INFLAMMATION OF THE FEET DEMONSTRATES SUBCLINICAL INFLAMMATORY DISEASE IN CUTANEOUS PSORIASIS PATIENTS WITHOUT CLINICAL ARTHRITIS', in ANNALS OF THE RHEUMATIC DISEASES, BMJ PUBLISHING GROUP, SPAIN, Madrid, pp. 727 - 727, presented at
, 2017, 'TREATMENT PATTERNS AMONG PATIENTS WITH RHEUMATIC DISEASE (RHEUMATOID ARTHRITIS (RA), ANKYLOSING SPONDYLITIS (AS) AND PSORIATIC ARTHRITIS (PSA)) TREATED WITH SUBCUTANEOUS TNF-ALPHA ANTAGONISTS', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 33 - 33, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000400304400097&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2017, 'A RANDOMISED DOUBLE-BLIND PLACE-BOCONTROLLED CROSSOVER TRIAL OF ADALIMUMAB FOR EROSIVE HAND OSTEOARTHRITIS: THE HUMOR TRIAL', in OSTEOPOROSIS INTERNATIONAL, SPRINGER LONDON LTD, ITALY, Florence, pp. S59 - S59, presented at
, 2017, 'Apremilast, an oral phosphodiesterase 4 inhibitor, is associated with long-term (104-week) improvement in fatigue in patients with psoriatic arthritis: Pooled results from 3 phase III, randomized, controlled trials', in JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, MOSBY-ELSEVIER, FL, Orlando, pp. AB47 - AB47, presented at
, 2017, 'A STUDY OF VAGUS NERVE STIMULATION FOR RHEUMATOID ARTHRITIS', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 27 - 27
, 2017, 'PATIENT REPORTED OUTCOMES (PROS) IN PATIENTS WITH RHEUMATIC DISEASES: USING THE OPAL REGISTRY TO LINK PROS WITH CLINICAL OUTCOME', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 32 - 33
, 2017, 'SAFETY AND TOLERABILITY OF SECUKINUMAB OVER LONG-TERM EXPOSURE IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS (PSA) AND MODERATE TO SEVERE PLAQUE PSORIASIS (PSO): UPDATED POOLED SAFETY ANALYSES', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 38 - 38
, 2016, 'A Placebo Controlled Trial of Vertebral Fill Technique Vertebroplasty for Acute Painful Osteoporotic Fracture (VAPOUR Trial)', in ARTHRITIS & RHEUMATOLOGY, WILEY, DC, Washington, presented at
, 2016, 'Enriching Rheumatoid Arthritis Trial Cohorts with Erosion Progressors By Screening for Active Erosions (Erosions with Osteitis) with MRI', in ARTHRITIS & RHEUMATOLOGY, WILEY, DC, Washington, presented at
, 2016, 'Real World Treat to Target Strategy in Rheumatoid Arthritis: Radiograph and MRI Outcomes in Three Cohorts with 18 Month Follow up', in ARTHRITIS & RHEUMATOLOGY, WILEY, DC, Washington, presented at
, 2016, 'Reliability and Responsiveness of an Omeract Tenosynovitis Magnetic Resonance Imaging Scoring System for the Rheumatoid Arthritis Wrist and Hand', in ARTHRITIS & RHEUMATOLOGY, WILEY, DC, Washington, presented at
, 2016, 'Tofacitinib: Treatment Outcomes in Seropositive Versus Seronegative Patients in a Phase 3 RA Population', in ARTHRITIS & RHEUMATOLOGY, WILEY, DC, Washington, presented at
Filter by type
https://orcid.org/0000-0002-2277-8337